We have tips on starting at amoxetine and Prezacin, and the FDA has a new warning on stimulants.

Welcome to the Carlet Psychiatry Podcast, keeping psychiatry honest since 2003.

I'm Chris Akin, the editor-in-chief of the Carlet Psychiatry Report.

And I'm Kelly Newsom, a psychiatric MP, and a dedicated reader of every issue.

One of the worst things we can do is cause a new patient to have terrible side effects

after their first dose of a medication.

They may never trust psychiatry again.

Today, you're going to learn how to reduce that risk with two meds,

Adamoxetine and Prazacin. Stay tuned to the end, where we have an update from our daily psych feed

on the FDA labeling of stimulants. Join the feed on LinkedIn, Twitter, Facebook, and Blue Sky.

Search for Chris Ake and MD.

Do you think of Adamoxetine, strata as a sedative? I don't. It's anoregenergic, so pumping up

adrenaline can't make people tired, right? But in a 2020 study, Andy Eugene looked into post-marketing

reports of somnolence on psychiatric medications

that had an antidepressant structure, like admoxatine does.

And in that study, atomoxetine topped the list for causing reports of severe somnolence.

The reason reveals a useful pearl in starting this non-stimulant for

ADHD. Most patients do not have somnolence on admoxatine. Only one in 20 report it. But when they do,

it's bad enough to make them stop the drug or cause their clinician to report it to the FDA.

When it rains, it pours. Here's why.

Like the antipsychotics we listed in last week's episode,

at amoxetine blood levels rise or fall on the whims of a single metabolic pathway.

...